Antiphospholipid syndrome in Greece: Clinical and immunological study and review of the literature

Angiology

Volumn 55, Issue 4, 2004, Pages 421-430

  Boura, Panagiota ^a,b   Tselios, Konstantinos ^a,b   Skendros, Panagiotis ^a,b   Kountouras, Jannis ^a,b  

^a Hippokration Hospital ^*

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CYCLOSPORIN A; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ADULT; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; EPIDEMIOLOGICAL DATA; EYE DISEASE; FEMALE; GREECE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; KIDNEY DISEASE; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PREGNANCY COMPLICATION; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GREECE; HUMANS; MALE; MIDDLE AGED; PREGNANCY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 3142757880     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970405500409     Document Type: Article

References (48)

1. Boura P: Antiphospholipid syndrome. In: Internal Medicine, vol. 2, Aristotelian University of Thessaloniki, ed 1. Thessaloniki: University Studio Press, 1998, pp 1270-1273.
2. Harris NE: Antiphospholipid syndrome. In: Reumatology, ed. 2, ed. by Klippel JH, Dieppe PA. London: Mosby, 1998, ch 7.35.
3. Chou T-NK, Hsu TC, Chen RM, et al: Parvovirus B19 infection associated with the production of antineutrophil cytoplasmic antibody and anticardiolipin antibody. Lupus 9:551-554, 2000.
4. Amigo MC, Khamashta MA: Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am 26:331-348, 2000.
5. 2- GPI and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients. Am J Med 106:417-423, 1999.
6. 2-GPI autoantibodies, annexin V binding and the antiphospholipid syndrome. Clin Exp Immunol 120:537-543, 2000.
7. Manfredi AA, Rovere P, Heltai S, et al: Apoptotic cell clearance in systemic lupus erythematosus. Arthritis Rheum 41:205-223, 1998.
8. Del Papa N, Guidali L, Sala A, et al: Endothelial cells as target for antiphospholipid antibodies. Arthritis Rheum 40:551-561, 1997.
9. Pittoni V, Ravirajan CT, Donohoe S, et al: Human monoclonal antiphospholipid antibodies selectively bind to membrane phospholipid and b2-GPI on apoptotic cells. Clin Exp Immunol 119:533-543, 2000.
10. 2GPI is the antigen for anticardiolipin autoantibodies. Clin Exp Immunol 115: 571-576, 1999.
11. Sorice M, Circella A, Misasi R, et al: Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipid antibodies. Clin Exp Immunol 122:277-284, 2000.
12. Carreras LO, Forastiero RR, Martinuzzo ME: Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 15:163-169, 2000.
13. Petri M: Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 15:145-150, 2000.
14. Bick RL, Baker WF: Antiphospholipid syndrome and thrombosis. Semin Thromb Hemost 25:333-350, 1999.
15. Samarkos M, Asherson RA, Loizou S: The clinical significance of IgA antiphospholipid antibodies (editorial). J Rheumatol 28:694-697, 2001.
16. 2GPI antibodies: Importance of IgA isotype. Clin Exp Immunol 117:574-579, 1999.
17. 2GPI antibodies: Association with thrombosis in patients with systemic lupus erythematosus. J Rheumatol 28:520-524, 2001.
18. Roman MJ, Salmon JE, Sobel R, et al: Prevalance and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am J Cardiol 87:663-666, 2001.
19. Vaarala O, Alfthan G, Jauhiainen M, et al: Cross reaction between antibodies to oxidised LDL and to cardiolipin in systemic lupus erythematosus. Lancet 341:923-925, 1993.
20. 2GPI and oxidised LDL. Circulation 103:941-946, 2001.
21. 2GPI in systemic lupus erythematosus. Clin Exp Immunol 115:561-566, 1999.
22. Lauwerys BR, Lambert M, Vanoverschelde JL, et al: Myocardial microangiopathy associated with the antiphospholipid syndrome. Lupus 10:123-125, 2001.
23. Gharavi AE, Pierangeli SS, Levy RA, et al: Mechanisms of pregnancy loss in antiphospholipid syndrome. Clin Obstet Gynecol 44:11-19, 2001.
24. Stone S, Khamashta MA, Poston L: Placentation, antiphospholipid syndrome and pregnancy outcome. Lupus 10:67-74, 2001.
25. Munoz-Rodriguez FJ, Font J, Cervera R, et al: Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis and Rheum 29:182-190, 1999.
26. Cervera R, Piette JC, Khamastha MA, et al: Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019-1027, 2002.
27. Rai R, Cohen H, Dave M, et al: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. BMJ 314:253-257, 1997.
28. Pattison NS, Chamley LW, Birdsall M, et al: Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomised controlled trial. Am J Obstet Gynecol 183:1008-1012, 2000.
29. Wilson WA, Gharavi AE, Koike T, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42:1309-1311, 1999.
30. Lockshin MD, Sammaritano LR, Schwartzman S: Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 43:440-443, 2000.
31. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982.
32. Klippel JH, Dieppe PA: Rheumatology, ed. 2. London: Mosby, 1998, ch 5.2.
33. Greaves M, Cohen H, Machin SJ, et al: Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Hematol 109:704-715, 2000.
34. Brey R: Differential diagnosis of central nervous system manifestations of the antiphospholipid antibody syndrome. J Autoimmun 15:131-137, 2000.
35. Joseph RE, Radhakrishnan J, Appel GB: Antiphospholipid syndrome and renal disease. Curr Opin Nephrol Hypertens 10:175-181, 2001.
36. Nochy D, Daugas E, Huong DL, et al: Kidney involvement in the antiphospholipid syndrome. J Autoimmun 15:127-132, 2000.
37. Asherson RA. Antiphospholipid antibodies, malignancies and paraproteinemias. J Autoimmun 15:117-122, 2000.
38. Yamada H, Kato EH, Kobashi G, et al: Recurrent pregnancy loss: Etiology of thrombophilia. Semin Thromb Hemost 27:121-129, 2001.
39. Schultz RD, Diego MJ: Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: Update on assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation. Semin Arthritis Rheum 29:267-285, 2000.
40. Franssen CF, Stegeman CA, Kallenberg CG, et al: Antiproteinase-3 and antimyeloperoxidase-associated vasculitis. Kidney Int 57:2195-2206, 2000.
41. Khamashta MA, Guadrado MJ, Mujic F, et al: Management of thrombosis in the antiphospholipid syndrome. N Engl J Med 332:993-997, 1995.
42. Majerus PW, Broze GJ, Miletich JP, et al: Anticoagulant, thrombolytic and antiplatelet drugs. In: The Pharmacological Basis of Therapeutics, Goodman and Gilman's, International Edition. New York: McGraw-Hill, 1996, pp 1346-1350.
43. Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 346:752-763, 2002.
44. Boura P, Tselios K, Mandalos A, et al: The antiphospholipid syndrome in patients with systemic lupus erythematosus from northern Greece (abstract). Clin Exp Rheumatol 20;272, 2002.
45. Esplin MS: Management of antiphospholipid syndrome during pregnancy. Clin Obstet Gynecol 44:20-28, 2001.
46. Laskin CA, Bombardier C, Hannah ME, et al: Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 337:148-153, 1997.
47. Rai R: Obstetric management of the antiphospholipid syndrome. J Autoimmun 15:203-207, 2000.
48. Branch DW, Peaceman AM, Druzin M, et al: A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 182: 122-127, 2000.